BACKGROUND: Quality of surgical care as a crucial component of a comprehensive multi-disciplinary management improves outcomes in patients with endometrial carcinoma, notably helping to avoid suboptimal surgical treatment. Quality indicators (QIs) enable healthcare professionals to measure their clinical management with regard to ideal standards of care. OBJECTIVE: In order to complete its set of QIs for the surgical management of gynecological cancers, the European Society of Gynaecological Oncology (ESGO) initiated the development of QIs for the surgical treatment of endometrial carcinoma. METHODS: QIs were based on scientific evidence and/or expert consensus. The development process included a systematic literature search for the identification of potential QIs and documentation of the scientific evidence, two consensus meetings of a group of international experts, an internal validation process, and external review by a large international panel of clinicians and patient representatives. QIs were defined using a structured format comprising metrics specifications, and targets. A scoring system was then developed to ensure applicability and feasibility of a future ESGO accreditation process based on these QIs for endometrial carcinoma surgery and support any institutional or governmental quality assurance programs. RESULTS: Twenty-nine structural, process and outcome indicators were defined. QIs 1-5 are general indicators related to center case load, training, experience of the surgeon, structured multi-disciplinarity of the team and active participation in clinical research. QIs 6 and 7 are related to the adequate pre-operative investigations. QIs 8-22 are related to peri-operative standards of care. QI 23 is related to molecular markers for endometrial carcinoma diagnosis and as determinants for treatment decisions. QI 24 addresses the compliance of management of patients after primary surgical treatment with the standards of care. QIs 25-29 highlight the need for a systematic assessment of surgical morbidity and oncologic outcome as well as standardized and comprehensive documentation of surgical and pathological elements. Each QI was associated with a score. An assessment form including a scoring system was built as basis for ESGO accreditation of centers for endometrial cancer surgery.

Clinical Research Unit Institut Bergonie Bordeaux France

Department of Gynaecologic Oncology Imperial College London Faculty of Medicine London UK

Department of Gynaecology and Gynaecologic Oncology University Oncology Center of Bialystok Medical University of Bialystok Bialystok Poland

Department of Gynecologic Oncology Nairi Medical Center Yerevan Armenia

Department of Gynecologic Oncology VKV American Hospital Istambul Turkey

Department of Gynecology and Gynecological Oncology Evangelische Kliniken Essen Mitte Essen Germany

Department of Gynecology and Obstetrics Gynecologic Oncology Leuven Cancer Institute Catholic University Leuven Leuven Belgium

Department of Gynecology and Obstetrics Technische Universität Dresden Dresden Germany

Department of Gynecology and Obstetrics; Innsbruck Medical Univeristy Innsbruck Austria

Department of Gynecology with Center for Oncological Surgery Campus Virchow Klinikum Charité Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Humboldt Universitätzu Berlin and Berlin Institute of Health Berlin Germany

Department of Obstetrics and Gynaecology University Hospital Munich Munich Germany

Department of Obstetrics and Gynecologic Oncology University Hospitals Strasbourg Strasbourg Alsace France

Department of Obstetrics and Gynecology 1st Faculty of Medicine Charles University General University Hospital Prague Prague Czech Republic

Department of Obstetrics and Gynecology Innsbruck Medical University Innsbruck Austria

Department of Obstetrics and Gynecology Koç University School of Medicine Ankara Turkey

Department of Obstetrics and Gynecology Memorial Sloann Kettering Cancer Center New York New York USA

Department of Obstetrics and Gynecology Skåne University Hospital Lund Sweden

Department of Surgery Institut Gustave Roussy Villejuif France

Division of Gynecologic Oncology Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma Lazio Italy

Faculty of Medicine and University Hospital Carl Gustav Carus Technische Universität Dresden Dresden Germany

German Cancer Research Center Heidelberg Germany

Gynecologic Oncology Unit La Paz University Hospital IdiPAZ Madrid Spain

Helmholtz Zentrum Dresden Rossendorf Dresden Germany

Lund University Faculty of Medicine Clinical Sciences Lund Sweden

National Center for Tumor Diseases Dresden Germany

Citace poskytuje Crossref.org

Predictors for sentinel lymph node mapping failure using indocyanine green injection in apparent early stages of endometrial cancer: A single-center prospective study